ACLL - ACell Inc
N/A
0 0%
Share volume: 0
Last Updated: Wed 01 Dec 2021 01:00:04 PM CET
Pharmaceuticals: Major:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
Summary score
36%
Profitability
25%
Dept financing
50%
Liquidity
29%
Performance
45%
Sector
Health Technology
Industry
Pharmaceuticals: Major
Long-term ratios 2016 - 2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-16.03%
Return on assets
-7.03%
Return on sales
-5.81%
Return on invested capital
16705.07%
Total debt ratio
57.24%
Debt ratio change over timeo
0%
Current Ratio
2.42%
Quick Ratio
1.62%
Cash Position Ratio
0.4%
Short-term ratios 2019 - 2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-16.03%
Return on assets
-7.03%
Return on sales
-11.57%
Return on invested capital
16705.07%
Total debt ratio
57.24%
Debt ratio change over timeo
0%
Current Ratio
2.42%
Quick Ratio
1.62%
Cash Position Ratio
0.4%
Last quarter ratios 2020
The data are presented for the financials results of the last quarter.
Return on equity
-16.03%
Return on assets
-7.03%
Return on sales
-11.57%
Return on invested capital
16705.07%
Total debt ratio
57.24%
Debt ratio change over time
0%
Current Ratio
2.42%
Quick Ratio
1.62%
Cash Position Ratio
0.4%
Performance ratios (change over 4 years) 2016 - 2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ACLL | FTSV | PRNB | RARX |
|---|---|---|---|---|
| Return on equity | -16.03% | -17.97% | -4.62% | -14.58% |
| Return on assets | -7.03% | -15.67% | -1.76% | -13.27% |
| Return on sales | -5.81% | 0% | 0% | 0% |
| Return on invested capital | 16705.07% | 161.19% | -572.22% | 733.8% |
| Profitability | 25% | 0% | 75% | 1% |
| Total debt ratio | 57.24% | 14.54% | 30.12% | 9.46% |
| Debt ratio change over time | 0% | -0.91% | -0.99% | -1% |
| Dept financing | 50% | 6% | 13% | 4% |
| Current Ratio | 2.42% | 9.08% | 14.62% | 18.6% |
| Quick Ratio | 1.62% | 0% | 0% | 0% |
| Cash Position Ratio | 0.4% | 3.84% | 2.56% | 18.04% |
| Liquididy | 30% | 17% | 22% | 50% |
| Short-term ratios | ACLL | FTSV | PRNB | RARX |
|---|---|---|---|---|
| Return on equity | -16.03% | -14.4% | -5.79% | -11.71% |
| Return on assets | -7.03% | -13.07% | -5.74% | -11.29% |
| Return on sales | -11.57% | 0% | 0% | 0% |
| Return on invested capital | 16705.07% | 125.66% | -74.96% | 758.6% |
| Profitability | 25% | 0% | 75% | 1% |
| Total debt ratio | 57.24% | 14.07% | 9.92% | 6.96% |
| Debt ratio change over time | 0% | -0.91% | -0.97% | -1% |
| Dept financing | 50% | 6% | 4% | 3% |
| Current Ratio | 2.42% | 9.08% | 14.62% | 18.6% |
| Quick Ratio | 1.62% | 0% | 0% | 0% |
| Cash Position Ratio | 0.4% | 3.84% | 2.56% | 18.04% |
| Liquididy | 29% | 18% | 23% | 50% |